CHNA

Loncar China BioPharma ETF
CHNA

Delisted

CHNA was delisted on the 20th of October, 2023.

Back to rankings

7 hedge funds and large institutions have $2.13M invested in Loncar China BioPharma ETF in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$346K
2
+$16.9K
3
+$15K
4
Osaic Holdings
Osaic Holdings
Arizona
+$1.12K

Top Sellers

1
-$237K
2
-$16.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.35M
2
$346K
3
$326K
4
$65K
5
$23K
6
$15K
7
$13K